Research on the impact of China's reform to delegate power, streamline administration, and optimize government services on the technology innovation efficiency of the pharmaceutical manufacturing industry

ObjectiveThe government has recently implemented reforms aimed at delegating power, streamlining administration, and optimizing government services. This reform has eliminated barriers that impede the growth of various industries, thereby unleashing innovative potential. Additionally, there have bee...

Full description

Saved in:
Bibliographic Details
Main Authors: Yang Gu (Author), Qian Zhuang (Author)
Format: Book
Published: Frontiers Media S.A., 2024-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_2b4599fc1c304056aee4e7ad27e07aa7
042 |a dc 
100 1 0 |a Yang Gu  |e author 
700 1 0 |a Qian Zhuang  |e author 
245 0 0 |a Research on the impact of China's reform to delegate power, streamline administration, and optimize government services on the technology innovation efficiency of the pharmaceutical manufacturing industry 
260 |b Frontiers Media S.A.,   |c 2024-01-01T00:00:00Z. 
500 |a 2296-2565 
500 |a 10.3389/fpubh.2024.1325298 
520 |a ObjectiveThe government has recently implemented reforms aimed at delegating power, streamlining administration, and optimizing government services. This reform has eliminated barriers that impede the growth of various industries, thereby unleashing innovative potential. Additionally, there have been several medical policies, including changes to medical insurance and centralized volume-based procurement. China's pharmaceutical market has undergone significant changes, leading to increased demands for innovation technology efficiency in pharmaceutical manufacturing.MethodsThe three-stage BCC theory was employed to assess the effectiveness of technology innovation in the industry under this reform. Calculate precise comprehensive technical efficiency values, pure technical efficiency values, and scale efficiency values for technological innovation in the pharmaceutical industry across 30 provinces from 2018 to 2020, after removing environmental factors.ResultsIn 2020, Jiangsu and Shandong and nine other provinces reached the comprehensive technical efficiency frontier surface, joining Tianjin, Zhejiang, and Guangdong provinces. However, Gansu, Qinghai, Ningxia, and Xinjiang still need to catch up due to their smaller industrial scale and lack of technology.DiscussionTo ensure the effectiveness of reforms, it is crucial to fully consider provincial differences. Articulating national and provincial policies is necessary to allow efficient provinces to continue and allocate resources toward less efficient provinces to improve overall efficiency. 
546 |a EN 
690 |a pharmaceutical industry 
690 |a innovation efficiency 
690 |a reform to delegate power 
690 |a streamline administration and optimize government services 
690 |a three-stage BCC model 
690 |a inter-provincial 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n Frontiers in Public Health, Vol 12 (2024) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fpubh.2024.1325298/full 
787 0 |n https://doaj.org/toc/2296-2565 
856 4 1 |u https://doaj.org/article/2b4599fc1c304056aee4e7ad27e07aa7  |z Connect to this object online.